Symbol | Exchange | Currency |
|---|
Sharecast - Oxford Biomedica said on Wednesday that its Oxford Biomedica Solutions unit had inked the deals with the undisclosed firms, with the subsidiary set to provide its full...
Investing.com - Oxford BioMedica reported on Thursday second quarter earnings that beat analysts' forecasts and revenue that topped expectations. Oxford BioMedica announced...
Determined to make the New Year better than the last, the European indices opened the first trading day of 2021 with much fanfare this Monday. Despite the rapid increase in daily...
Watch our week ahead video preview, read our pick of the top stories to look out for this week (14-18 September), and view our key company earnings schedule. Our UK chief market...
Shares in Oxford Biomedica (LON:OXB) have outperformed the market over the past three months, signalling optimism on the part of investors at a time of economic uncertainty. Based...
Oxford Biomedica Plc is a United Kingdom-based fully integrated, cell, and gene therapy company. Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patients cells. The Company’s segments include Platform and Product. The Platform segment includes bioprocessing and process development activities for third parties. It also includes internal technology developments and technical intellectual property within the LentiVector platform. The Product segment consists of the clinical and pre-clinical development of in vivo and ex vivo cell and gene therapy products (gene therapeutics). Its product pipeline includes OXB-302, OXB-40X, OXB-40Y, Axo-Lenti-PD, and OXB-40Z. Its lead program is OXB-302, which targets 5T4, which is being investigated in Acute Myeloid Leukemia. It works across viral vector delivery systems including those based on lentivirus, adeno-associated virus (AAV), and adenovirus.
| Average | 1,070.29 (+137.84% Upside) |
| High | 2,400.00 |
| Low | 397.00 |
| Price | 450.00 |
| No. of Analysts | 7 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Sell | Sell | Buy | Strong Buy | Sell |
| Technical Indicators | Sell | Strong Sell | Buy | Strong Buy | Strong Sell |
| Summary | Sell | Strong Sell | Buy | Strong Buy | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 19.36 | 20.15 | 19.28 | -0.36 | -1.83% | 4.79M | London | |||
| 243.70 | 243.70 | 231.70 | +11.70 | +5.04% | 4.15M | London | |||
| 516.40 | 516.40 | 488.00 | +38.05 | +7.95% | 84.50M | London | |||
| 431.50 | 445.00 | 431.00 | -5.5 | -1.26% | 183.38K | London | |||
| 1,012.00 | 1,028.00 | 1,007.00 | -14.00 | -1.36% | 1.11M | London | |||
| 158.00 | 158.00 | 158.00 | +7.00 | +4.64% | 45.94K | London | |||
| 330.60 | 337.40 | 324.20 | +2.00 | +0.61% | 864.29K | London | |||
| 1.10 | 1.10 | 1.10 | -0.025 | -2.22% | 1.96M | London | |||
| 333.30 | 336.25 | 329.55 | +2.65 | +0.80% | 10.69M | London | |||
| 117.20 | 125.00 | 116.40 | -6.20 | -5.02% | 336.10K | London | |||
| 115.00 | 116.50 | 114.00 | 0.00 | 0.00% | 0.00 | London | |||
| 42.00 | 43.80 | 42.00 | +1.70 | +4.22% | 1.00M | London | |||
| 5,754.00 | 5,790.00 | 5,718.00 | -30.0 | -0.52% | 903.73K | London | |||
| 14.75 | 14.90 | 14.51 | 0.00 | 0.00% | 35.70K | Aquis Exchange | |||
| 62.95 | 65.75 | 62.05 | -1.05 | -1.64% | 38.37K | London |